Newsfeeds - Spark Newswire

2 minute read

Combatting The ‘Bad Trip’: New Research Project Seeks Solutions That Go Beyond Psychedelics

Today, 5:20 AM

Ehave, Inc. (OTC: EHVVF) has completed the first of three planned phases of its studies with the University of Melbourne to determine the cause and possible cure for hallucinogen-persisting perception disorder (HPPD).

EHVVF

2 minute read

FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder

By Lara Goldstein

Today, 5:20 AM

After a full review of healthcare provider Ehave Inc.'s (OTC Pink: EHVVF) IND application, the U.S.

EHVVF

5 minute read

Psyched: Christie’s Launches NFT Collection Supporting Psychedelic Science, Origin’s Listing On CSE Gives Retail Investors Access To Private Companies

By Natan Ponieman

Today, 5:20 AM

The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.

CMNDF

2 minute read

Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research

By Lara Goldstein

Today, 5:20 AM

Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treating brain health.

EHVVF

6 minute read

Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study

By Natan Ponieman

Today, 5:20 AM

Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. A new Johns Hopkins review study found that the positive effects of just two sessions of psilocybin-assisted psychotherapy can last for over one year in most patients with depression.

CYBN

2 minute read

KetaDASH Announces Mobile Ketamine Treatments in San Francisco and Sacramento Area

By Nicolas Jose Rodriguez

Today, 5:20 AM

Ehave, Inc.

EHVVF

5 minute read

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai’s New Subsidiary, PharmaTher Gets New Orphan Drug Designation

By Natan Ponieman

Today, 5:20 AM

The Week In Psychedelics

AGNPF

2 minute read

There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are

By Natan Ponieman

Today, 5:20 AM

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.

AGNPF

4 minute read

Cannabis Movers & Shakers: Greenlight Distribution, Petalfast, Tinley Beverage, Shryne Group, Ehave, NY Cannabis Control Board

By Jelena Martinovic

Today, 5:20 AM

Greenlight Distribution Hires Erik Elder As New Director Of Sales Greenlight Distribution, a leading seller of products and a direct lender to U.S. commercial cannabis cultivators, reported Wednesday that the company has hired Erik Elder as its new director of sales.

CCE